Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective

Authors

  • Ralph M. Meyer Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON; Department of Community Health and Epidemiology, Queen’s University, Kingston, ON
  • Heather A. Stanton Department of Oncology, Queen’s University, Kingston, ON
  • Wendy R. Parulekar Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON
  • Fred Saad Department of Oncology, Queen’s University, Kingston, ON; Department of Surgery, Université de Montréal, Montreal, QC

DOI:

https://doi.org/10.5489/cuaj.763

Abstract

Downloads

Download data is not yet available.

Author Biographies

Ralph M. Meyer, Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON; Department of Community Health and Epidemiology, Queen’s University, Kingston, ON

Heather A. Stanton, Department of Oncology, Queen’s University, Kingston, ON

Wendy R. Parulekar, Department of Oncology, Queen’s University, Kingston, ON; Department of Medicine, Queen’s University, Kingston, ON

Fred Saad, Department of Oncology, Queen’s University, Kingston, ON; Department of Surgery, Université de Montréal, Montreal, QC

Downloads

How to Cite

Meyer, R. M., Stanton, H. A., Parulekar, W. R., & Saad, F. (2013). Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective. Canadian Urological Association Journal, 5(6), 379–81. https://doi.org/10.5489/cuaj.763

Issue

Section

Letters